Conclusion
The continental French population has one of the highest antibiotic exposures and one of the highest rates of antimicrobial resistance among European countries and perhaps among all countries in the world. However, several years ago, stopping the spread of antimicrobial resistance became a public health priority. Now, public health authorities, scientists, and health professionals are highly motivated and mobilised to lower antibiotic use, while maintaining optimal clinical efficacy of antimicrobials.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agence Nationale pour le Développement de l’Evaluation Médicale, 1996, Bon usage des antibiotiques à l’ hôpital. Recommandations pour maîtriser le développement de la résistance bactérienne. Service des Etudes, Paris.
Bouvenot, G., 1999, Prescriptions and consumption of venotonic drugs in France (a propos of the report of the French National Institute for prescriptions and consumption of drugs). Bull. Acad. Natl. Med., 183, 865–875, discussion 875–878.
Bronzwaer, S. L., Cars, O., Buchholz, U. et al., 2002, A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8, 278–282.
Butler, C. C., Rollnick, S., Pill, R., Maggs-Rapport, F., and Stott, N., 1998, Understanding the culture of prescribing: Qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ, 317, 637–642.
Carbon, C., Guillemot, D., Paicheler, G., Feroni, I., Lamar, L., and Aubry-Damon, H., 2002, Rapport d’évaluation 2002 de la campagne menée par le Groupe d’Etude et de Prévention des Infections de l’ Enfantpour une utilisation prudente des antibiotiques chez l’enfant. Alpes Maritimes, 1999–2005. Institut de Veille Sanitaire, Saint Maurice, France.
Cars, O., Molstad, S., and Melander, A., 2001, Variation in antibiotic use in the European Union. Lancet, 357, 1851–1853.
Cremieux, A., Reveillaud, O., and Schlemmer, B., 2001, Plan national pour préserver l’efficacité des antibiotiques. Ministère de la Santé, Paris. http://www.sante.gouv.fr/htm/actu/antibio.
Direction des Etudes Médico-Economiques et de l’Information Scientifique, Agence Française de Sécurité Sanitaire des Produits de Santé, 2002, Etat des lieux en 1999–2000 dans les établissements de santé de l’existence de recommendations pour la prescription et des modalités de dispensation des antibiotiques. Paris, France.
Elseviers, M., Ferech, M., Vanderstichele, R., and Goossens, H., 2003, Consumption of ambulatory care in Europe. In European Conference of Clinical Microbiolgy and Infectious Diseases. Glasgow.
European Federation of Pharmaceutical Industries and Associations, 2003, The Pharmaceutical Industry in Figures. Brussels, Belgium, http://www.efpia.org.
Fenina, A. and Geffroy, Y., 2002, Comptes nationaux de la Santé 2002. Ministère de la Santé, Paris. http://www.sante.gouv.fr.
Garattini, S., 1998, The drug market in four European countries. Pharmacoeconomics, 14(Suppl. 1), 69–79.
Groupe de travail sur la Maîtrise de la résistance aux antibiotiques, 1999, Propositions au Secrétaire d’Etat à la Santé età l’ Action Sociale pour unplan national d’actions pour la maîtrise de la résistance aux antibiotiques. Réseau National de Santé Publique, Saint-Maurice, France.
Guillemot, D. and Courvalin, P., 2001, Better control of antibiotic resistance. Clin. Infect. Dis., 33, 542–547.
Guillemot, D., Maison, P., Carbon, C. et al., 1998, Trends in antimicrobial drug use in the community-France, 1981–1992. J. Infect. Dis., 177, 492–497.
Hamm, R. M., Hicks, R. J., and Bemben, D. A. 1996. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met? J. Fam. Pract., 43, 56–62.
Holmes, S. J., Morrow, A. L., and Pickering, L. K., 1996, Child-care practices: Effects of social change on the epidemiology of infectious diseases and antibiotic resistance. Epidemiol. Rev., 18, 10–28.
Lancry, P. J., Pigeon, M., and Criquillion, B., 2002, MEDICAM: Les médicaments remboursés par le Régime Général d’Assurance Maladie au cours des années 2000 et 2001. Caisse Nationale d’Assurance Maladie des Travailleurs Sociaux, Paris.
Macfarlane, J., Holmes, W., Macfarlane, R., and Britten, N., 1997. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ, 315, 1211–1214.
Melander, E., Ekdahl, K., Jonsson, G., and Molstad, S., 2000, Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr. Infect. Dis. J., 19, 1172–1177.
Nasrin, D., Collignon, P. J., Roberts, L., Wilson, E. J., Pilotto, L. S., and Douglas, R. M., 2002, Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: Prospective cohort study. BMJ, 324, 28–30.
Observatoire National des Prescriptions et Consommations des Médicaments, 1998, Etude de la prescription et de la consommation des antibiotiques en ambulatoire. Agence du Médicament, Direction des Etudes et de l’Information Pharmaco-Economiques, Paris.
Pelissolo, A., Boyer, P., Lepine, J. P., and Bisserbe, J. C., 1996, Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world. Encephale, 22, 187–196.
Pradier, C., Dunais, B., Ricort-Patuano, C. et al., 2003, Campagne “Antibios quand il faut” mise en place dans le département des Alpes Maritimes. Méd. Mal. Infect., 33, 9–14.
Quatrième Conférence de Consensus en Thérapeutique Anti-Infectieuse, 1992, Les Infections des Voies Respiratoires. Méd. Mal. Infect., 22, 38–201.
Sommet, A., Sermet, C., Boëlle, P. Y., Tafflet, M., Bernède, C., and Guillemot, D. Trends in antibiotic use in the French community, from 1992 to 2000. submitted.
Wessling, A. and Boethius, G., 1990. Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur. J. Clin. Pharmacol., 39, 207–210.
WHO Collaborating Center for Drug Statistics Methodology, 2001, Guidelines for ATC classification and DDD assignment. Oslo, Norway, http://www.whocc.no/atcddd.
WHO Estimation of Health Personnel, 2003, WWO Statistical Information System, http://www3.who.int/whosis/health_personnel.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Sommet, A., Guillemot, D. (2005). Antibiotic Use in the Community: The French Experience. In: Gould, I.M., van der Meer, J.W.M. (eds) Antibiotic Policies. Springer, Boston, MA. https://doi.org/10.1007/0-387-22852-7_30
Download citation
DOI: https://doi.org/10.1007/0-387-22852-7_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48500-8
Online ISBN: 978-0-387-22852-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)